Recent Publications

Articles

• Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer.
  Destouches D, Sader M, Terry S, Marchand C, Maillé P, Soyeux P, Carpentier G, Semprez F, Céraline J, Allory Y, Courty J, De La Taille A, Vacherot F : Oncotarget, 2016
• Implication de la molécule X dans la récidive du cancer de prostate (CaP) localisé.
  Champy C, Semprez F, El Sayed I, Maille P, Soyeux P, Allory Y, Vacherot F, De La Taille A, Firlej V : Prog Urol, 2015
• CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.
  Terry S, El-Sayed IY, Destouches D, Maillé P, Nicolaiew N, Ploussard G, Semprez F, Pimpie C, Beltran H, Londono-Vallejo A, Allory Y, de la Taille A, Salomon DS, Vacherot F : Oncotarget, 2015
• Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.
  Terry S, Nicolaiew N, Basset V, Semprez F, Soyeux P, Maillé P, Vacherot F, Ploussard G, Londoño-Vallejo A, de la Taille A, Allory Y : Cancer, 2015
• FKBP12.6 mice display temporal gender differences in cardiac Ca(2+)-signalling phenotype upon chronic pressure overload.
  Prévilon M, Pezet M, Semprez F, Mercadier JJ, Rouet-Benzineb P : Can J Physiol Pharmacol, 2011